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Abstract
The proteins in blood were all first
expressed as mRNAs from genes within cells.
There are databases of human proteins that
are known to be expressed as mRNA in
human cells and tissues. Proteins identified
from human blood by the correlation of mass
spectra that fail to match human mRNA
expression products may not be correct. We
compared the proteins identified in human
blood by mass spectrometry by 10 different
groups by correlation to human and nonhu-
man nucleic acid sequences. We determined
whether the peptides or proteins identified by
the different groups mapped to the human
known proteins of the Reference Sequence
(RefSeq) database. We used Structured Query
Language data base searches of the peptide
sequences correlated to tandem mass spec-
trometry spectra and basic local alignment
search tool analysis of the identified full
length proteins to control for correlation to the
wrong peptide sequence or the existence of the
same or very similar peptide sequence shared
by more than one protein. Mass spectra were
correlated against large protein data bases that
contain many sequences that may not be
expressed in human beings yet the search
returned a very high percentage of peptides or
proteins that are known to be found in
humans. Only about 5% of proteins mapped
to hypothetical sequences, which is in agree-
ment with the reported false-positive rate of
searching algorithms conditions. The results
were highly enriched in secreted and soluble
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Introduction
High-throughput tandem mass spectro-
metry (MS/MS) based peptide correlation
analysis of complex biological samples yields
long lists of proteins (1). Serum may contain
most human proteins (2) but most are not
detectable by chromatography followed by
polyacrylamide gel electrophoresis (PAGE) (3).
Liquid chromatography (LC)-based
approaches have been shown to detect more
proteins than PAGE-based approaches (4,5).
The peptides reported from superabundant
proteins have often proved to be purely tryp-
tic peptides with few missed cleavage sites.
However, some of the peptides from appar-
ently low abundance proteins have reportedly
resulted from nontryptic activities or con-
tained missed cleavage sites. Trypsin cleaves
exclusively on the C terminal side of lysine or
arginine (6) and this may lead to the percep-
tion that some of the nontryptic peptides
reported in sera may be artifacts of searching
(7). The groups have used different sample
preparation methods including LC-PAGE (3),
LC/LC-MS/MS (5,8–10), iso-electric focusing
(11), no sample preparation followed by ultra
high-performance liquid chromatography
(HPLC) (9), with fractionation followed by
ultra HPLC (12), and after low molecular mass
filtration (13). We obtained the published pro-
tein expression lists generated by 10 research
groups from the MS analysis of human blood.
The protein expression lists were obtained by
searches of MS/MS spectra against both
human and nonhuman sequences and against
known proteins (NP) vs hypothetical gene
products whose expression is unknown (XP).
Most proteins have been identified by MS/MS
with collision-induced dissociation of tryptic
disgests from blood proteins. These fragmenta-
tion spectra were correlated to as many proteins
as possible from a comprehensive protein
databases (8). A number of correlation algo-
rithms have been developed and tested empir-
ically to determine the scoring parameters that
result in acceptable false-positive rates of
about 5% (14,15–19) based on searches of both
real and nonphysiological protein databases
(6,8,17), but this alone may not be sufficient to
ensure correct identification (7).
The proteins in blood were all first expressed
as mRNAs from genes within cells. There are
data banks of known human expression prod-
ucts such as the Reference Sequence (RefSeq)
NP database (Fig. 1). Proteins identified from
human blood that fail to match expressed
human mRNAs may be suspect. We compared
the protein identified in human blood by mass
spectrometry (MS) from 10 different groups.
We determined whether the peptides or pro-
teins identified by the different groups are NP
that have been shown to be expressed as
mRNA in human beings. There are two ways
that correlation of mass spectrometry data to
nucleic acid sequences might be in error: the
spectra may be correlated to the wrong pep-
tide sequence or the same or very similar pep-
tide sequence might be shared by more than
one protein. To control for these two possibil-
ities we used Structured Query Language
(SQL) database searches of the peptide
sequences and basic local alignment search
tool (BLAST) analysis of the identified full
proteins and diminished in insoluble or
membrane proteins. Most of the proteins iden-
tified were relatively short and showed a sim-
ilar size distribution compared to the RefSeq
database. At least three groups agree on a
nonredundant set of 1671 types of proteins
and a nonredundant set of 3151 proteins were
identified by at least three peptides.
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length proteins. Different algorithms have
been used to combine and compare data sets
and to determine high confidence identifica-
tions from correlations against known human,
nonhuman, or hypothetical protein sequences
(20). We assembled nonredundant lists of
normal serum proteins with homology to
known human transcripts (21) or the predicted
transcription sites of the human genome (22).
Materials and Methods
Databases
Publicly available databases of blood pro-
teins from MS analysis that are markedly dif-
ferent have been assembled by the Johns
Hopkins/Bio-Informatic Institute and HUPO
(20,23). We obtained the published serum and
plasma proteomic data and parsed the
accession numbers to obtain FASTA protein
sequences (5,8,9,11–13,23). Where available,
the peptide sequences that were correlated to
MS/MS fragmentation spectra were parsed.
The protein and peptide sequences were used
directly for comparisons or transformed to a
common RefSeq format by BLAST matching
or exact string searches for MS/MS peptide
sequences. RefSeq is a comprehensive, non-
redundant database of human transcripts
together with their genomic loci and gene
ontology (GO) annotations (24) that was used
as the basis of comparison between groups
and category distributions. Except where indi-
cated, the July 2004 Human RefSeq database
was used for these calculations and contains a
total of 29,234 entries with 23,888 NP and 5333
XP entries. RefSeq is nonredundant in the
sense that few or none of the FASTA
sequences are exactly the same but many have
very similar sequences, or share subsets of
amino acid sequences or are of different
lengths or types. We previously obtained a
serum proteome via the calculation of many
LC-MS/MS runs separately using discrete,
individual sequest searches for pure tryptic
Fig. 1.The size distribution of blood proteins identi-
fied by mass spectrometry compared to the RefSeq
database. (A) Histogram showing the size distri-
bution of the RefSeq database (open bars) vs the
nonredundant MS data (closed bars); (B) plots of
the size distribution of proteins of 3000 amino
acids or less by for RefSeq (top solid line) MS vs
redundant proteins identified by one to five peptides
shown in descending order; (C) plots of the run-
ning total of size distribution of the MS data from
RefSeq (top solid line) vs redundant proteins identi-
fied by at least one to five peptides shown in
descending order. The axi are number of proteins
and abscisa are protein length in amino acids.
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peptides with X-Corrs or 1.5, 2.5, or 3.75 for
1+, 2+, and 3+ ion, respectively to yield a list
of some 600 proteins after manual editing. 
We have recalculated these many LC-MS/MS
runs together using the SEQUEST software
(15–17) and the conditions previously des-
cribed (5). The database was downloaded
from NR databse (NCBI) in April 2003 using
any FASTA headers that contained human,
homo (25), or sapiens but excluding headers
containing virus, viral, or HIV. This resulted
in a list of 2681 proteins identified by their
NCBI database GI numbers that were pre-
sented at the HUPO meeting in 2003. We com-
pared the results of searching a set of 110
LC-MS/MS runs either as individual discrete
files or on joint computation of multiple LC-
MS/MS runs using the May 2003 database
version of RefSeq that contains 18,455 NPs
and 18,887 XPs. We found that about 80% of
the hits to RefSeq were NP entries. Based on
the two-by-two contingency table of NP and
XP frequencies, Fisher’s exact test indicated
that there was a probability value of 3.82E-169
that the multiple run list was randomly sam-
pled from the RefSeq database. The protein
list generated from multiple LC-MS/MS cal-
culations was much larger than the list gener-
ated from the joint calculation of multiple
LC-MS/MS and the rate of XP entries increased
from 22 to 25% when runs were calculated
together.
Matching to Human RefSeq Proteins
We used two methods, one based on the
small peptides identified by MS/MS frag-
mentation and one based on the full length
sequence of the proteins implicated to assem-
ble representative lists of nonredundant pro-
teins for the purpose of comparing across
groups.
Exact MS/MS Peptide String Searches
We used the exact peptide sequence corre-
lated in the MS/MS experiment to search for
that string of amino acids. The set of peptides
discovered by each group were collapsed into
the set of longest unique peptide sequences.
These sequences were used as search strings
against the FASTA files of RefSeq. The amino
acid sequences of the resulting RefSeq FASTA
files were in turn collapsed into the set of
longest representative FASTA sequences that
still contained the original FASTA sequence
and, therefore, still contained the MS/MS
peptides. All these data base steps were per-
formed with a SQL database on a Windows
operating system personal computer.
BLASTp Matching
These serum protein lists were compared to
each other, as well as to the RefSeq database,
using the publicly available BLAST (26) search
engine downloaded from NCBI. We used 75%
sequence identity over the full length (FL) of
the entire identified protein as a criterion to
collapse many proteins into one top scoring
entry. The top scoring BLASTp alignment for
every query protein was considered a “match”
if the FL identity was greater than 75%, and if
the alignment contained a perfect match string
of at least 20 amino acids (26).
Comparison Between Experimental
Groups
We assembled the complete FASTA sequences
from all groups and assembled a nonredun-
dant database using SQL. We then used the
exact MS/MS peptides string searches and the
BLASTp matching methods against the nonre-
dundant database to determine agreement
across groups.
Protein Localization, Gene Ontology
Terms, Biological Process,
or Molecular Function
The proteins were categorized into intracel-
lular and extracellular compartments by GO
terms to classify protein localization in broad
categories such as cytoplasmic, membrane,
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mitochondrial, nuclear, secreted, and unclas-
sified. To associate the biological processes
and molecular functions from the GO (27), the
GO database was downloaded from the Gene
Ontology Consortium website and installed
as a MySQL database on a Windows 2000
workstation. Following the methods of Camon
et al. (28), the generic GOSlim file (goslim_
generic.obo), gene ontology file (gene_ontol-
ogy.obo), and the Perl utility script
(map2slim.pl) were downloaded from the
same website. Map2slim.pl script was modi-
fied to accommodate our input and output
file format. The protein GI numbers identified
by correlation analysis were mapped to
RefSeq proteins and the corresponding RefSeq
ids and their associated GO identifiers were
obtained from the gene2refseq, gene2go file
downloaded from NCBI. This file was run
through the modified map2slim.plscript,
which collapsed the original GO ids repre-
senting the furthest leaves of the ontology
onto the abbreviated GO Slim ontology.
Category Distributions 
and Chi-Square Statistic
The Chi-square statistic was computed for
each GO class, i.e., molecular function, biolog-
ical process, or cellular location. We used the
chi-square statistic to compare distributions of
proteins classified into multiple categories
compared to the distribution of the entire
RefSeq database as the reference. The Chi-
square statistic is defined as Σ(Oi – Ei)2/Ei,
where Oi is the observed frequency of ele-
ments in the ith category of the test set, Ei is
the expected frequency for the same category,
and the sum is overall categories i = 1, 2,…, N
in the classification scheme. The significance of
Chi-square for each category was evaluated as
if it were a two-way classification, that cate-
gory vs all other, using a cutoff value of chi-
square around nine, corresponding to a p-value
of about 0.0027. The low p-value cutoff is used to
correct for multiple-hypothesis testing, because
there are 27 categories being evaluated. To a
first approximation, expected number of false-
positives is equal to (p-value cutoff)*(Number of
categories tested). This approach is conceptually
similar to the hypergeometric method that was
used previously (29,30).
Size Distribution of Human Plasma 
and Serum Database
We used SQL to connect the identified pep-
tides to their full length FASTA sequence and
calculated the number of proteins in incre-
ments of 100 amino acids in length.
Results
Assembling NR Human RefSeq 
Databases by Exact MS/MS 
Peptide String Search
We parsed the files where the MS/MS pep-
tide sequence data were available to collect the
set of non-redundant peptides and we refer to
the results by the author or institution that
supplied the data. We collapsed the peptide
data into the longest set of representative pep-
tides, matched these peptides to RefSeq, and
then collapsed these results to the longest rep-
resentative full-length FASTA sequences. The
result was that the MS/MS peptide sequences
were mapped to the longest sequences in
the database that contained the exact MS/MS
peptide sequences. Using the data from
Table 1 in Shen et al. (12) as an example, we
collapsed 6371 smaller peptides into 4209 rep-
resentative longer peptides that contained the
other sequences. We then found these repre-
sentative, exact MS/MS peptides in 5959
RefSeq proteins. The protein sequences were
likewise collapsed into the 2704 longest repre-
sentative proteins that still contained the
original protein and the MS/MS peptide
sequences. The peptide sequences were used
to create a nonredundant set of 2704 RefSeq
proteins identified by Shen et al. (12) that still
contained an exact match to the peptides from
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that paper. The groups had an average of 95%
NP and 5% XP proteins and thus showed a
strong bias toward expressed human RefSeq
proteins and away from hypothetical proteins
(Table 1). Because the NP entries tended
toward agreement between groups but the XP
entries tended to diverge between groups the
NR set yielded 89% known NP and 8%
unknown XP entries.
Comparisons Between Experimental
Groups by MS/MS Peptides
Searches against the exact short peptide
sequence correlated by MS/MS algorithms
(Table 2) were used to calculate the agree-
ment on similar proteins across groups. Most
groups showed significant overlap by MS/MS
peptide searches. The correlated short peptide
sequences showed agreement in trends with
the full length protein sequences. Most groups
showed strong agreement, typically about 60%
with the HUPO PPP database, but it is not
clear if the data sets were strictly independent
in all cases.
Agreement Between BLAST Matching 
and Exact MS/MS Peptide Matching
The proteins matched to RefSeq by BLAST
matching were compared to proteins mapped
using the MS/MS peptide sequences where
both types of data were available (Table 3).
Peptide sequence string searches yielded
considerable agreement with BLAST analysis
showing similar trends and related FASTA
sequences. All of the FASTA sequences
obtained by 75% FL and 20 contiguous amino
acids still contained the exact original MS/MS
peptide sequences. The exact MS/MS string
search and BLASTp matching both obtained a
relevant set of nonredundant RefSeq proteins.
The data collapsed to the identical RefSeq
entry by both methods up to 30–40% of the
time and the nonredundant set of proteins
defined by BLAST matching still contained the
exact MS/MS peptide sequence method in all
of the entries. The similar set of related sequen-
ces obtained by the BLAST method (Table 4)
indicates that either method is sufficient to
map sets of LC/LC-MS/MS to a representa-
tive, nonredundant set of sequences to facili-
tate comparisons (Table 5). Using the PPP data
as an example, the peptide method shows an
NR set of some 9303 proteins by MS/MS pep-
tide but an NR set of 6654 proteins by the
BLAST method. The number of total nonre-
dundant proteins estimated by the peptide
method was 9303 and was in close agreement
with the PPP estimate of 9504 proteins. Simi-
larly, the number of proteins with two different
peptides in the PPP data set (3020) was similar
to the 3761 proteins we observed by the exact
MS/MS peptide method and apparently not in
sharp disagreement with previous results (23).
In general it appeared that the MS/MS peptide
method led to about a 50% larger set of NR
protein types compared to the BLAST method.
Assembling NR Human RefSeq 
Databases by BLAST Matching 
of Protein FASTA Files
We used BLASTp to match the proteins
identified by the correlation analysis of spectra
generated by LC-MS/MS against many differ-
ent protein databases to the human RefSeq
database. We used FASTA files from protein
gi, IPI, or other database numbers and then
mapped to the reference set of 29,234 RefSeq
proteins. The mapping to RefSeq was per-
formed by BLASTp matching of 75% full
length and by exact peptide sequence string
searches of greater than or equal to 20 con-
tiguous amino acids. This mapping was many-
to-one, collapsing closely related variants from
the original list to a single representative
RefSeq entry. We observed that most groups
showed a high percentage of identified pro-
teins that have close homologues in the NP
RefSeq (Table 4). We observed that all groups
obtained a large number of proteins identified
in serum that mapped to the RefSeq NP
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database. Most groups showed a comparably
low percentage of XP entries. Two groups
showed between 10 and 50% homology of full
length FASTA with RefSeq by BLAST map-
ping. The vast majority of the proteins identi-
fied by the various groups, often or mostly
against databases that contain a significant
proportion of hypothetical and nonhuman
entries, had close homologues with exact pep-
tide sequence matches to the known expres-
sion products of a human being. In general
BLAST mapping resulted in a markedly
smaller set of NR proteins compared to pep-
tide string searches.
Comparisons Between Experimental
Groups by BLAST of FASTA Sequences
Compared to the smaller residual data sets
left by BLAST matching (Table 5), the peptide
method (Table 2) showed larger absolute
numbers of proteins and thus typically
greater agreement between groups. Many
data sets showed typically from 30 to 40%
and up to 80% agreement. Because the exact
MS/MS peptide method resulted in a larger
set of related sequences that still contained
the same MS/MS peptides, there was a con-
comitantly greater degree of overlap com-
pared to the calculated overlap based on
BLAST. There was a general agreement in
trends between the two methods.
Category Distributions
String searches of exact peptide sequences
that had been correlated with MS/MS frag-
mentation spectra by different authors led to a
related set of protein sequences as compared
by BLAST. Peptides are available for only
some groups, but all groups have FASTA
accession numbers corresponding to full
length FASTA files. The BLASTp algorithm
(26) was used to compare all available data
sets (Table 6). The proteins listed in RefSeq
have the available GO terms and other infor-
mation linked to the entry. We compared the
category distributions of data sets from the
groups to that of the RefSeq database. We
observed that most groups identified an over-
abundance of secreted proteins such as extra-
cellular proteins, or proteins that are shed
from epithelium such as cytoskeletal proteins
and soluble proteins from the cytoplasm.
Conversely, ribosomal and mitochrondrial
proteins and other insoluble proteins from the
membranes appeared either with lower than
expected frequencies or were not detected. We
observed that Chi-square values for individ-
ual groups showed significant deviations from
the category distribution of the RefSeq data set
and thus did not appear to be randomly dis-
tributed over all categories.
NR Human Serum and Plasma Database
Because all groups provided accession
numbers, we used the BLAST method to cal-
culate a NR serum and plasma protein
database. We collected the full-length protein
sequences FASTA files related to the acces-
sion numbers reported by each group and
combined them into a SQL database. We
then used BLAST matching at 75% FL and 
20 contiguous AA to determine the level of
agreement between all groups. The total
reported number of approx 37,000 proteins
(Table 4) collapsed into some 19,196 proteins
after BLASTing. We observed perfect agree-
ment in all 10 groups on a set of four repre-
sentative proteins, complement C3, gelsolin,
transferin, and clusterin isoform 1 (Table 6).
Nine groups were in agreement on the top
15 sequences, four groups agreed on the top
455 sequences and at least three groups
agreed on a set of 1671 types of proteins
using the BLAST method assuming indepen-
dence between groups and institutions. It
was clear that SQL analysis of peptides and
BLAST analysis of full-length protein
sequences were able to collapse and compare
the available data sets against a reference
data base in a standardized manner.
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Size Distribution of Serum and Plasma
Protein Database
We examined the size distribution of the
RefSeq NP data base broken into 100 amino
acid increments and observed that NP proteins
show a maximum of about 400–600 amino
acids and that the most populated categories
are less than 1000 amino acids in length. The
proteins identified by mass spectrometry also
show a maximum of 400–600 amino acids and
that the population of categories declines to
low levels after about 1000 amino acids. There
are proteins in the RefSeq data base with sizes
up to 33,500 amino acids in length but each size
category only contains a small number of pro-
teins and similarly small number of proteins
were observed by mass spectrometry. The size
distribution of peptides from proteins identified
by two or more peptides remains below the
size distribution curve of the RefSeq data base.
Discussion
Blood contains a small group of high abun-
dance proteins mixed together with a very
diverse group of low abundance proteins that
have somehow diffused into the blood from
tissues and cells (2). The abundant proteins
that are maintained at high concentrations
within the fluid of the blood are constantly
secreted into the circulatory system. Endocrine
or pericrine proteins in the tissues or circula-
tory system (2) may typically have concentra-
tions in the low micromolar to high picomolar
range. In contrast, proteins leaking from dam-
aged cells might be in very low concentrations,
may not include secretion signals and may
include proteins released from the cells owing
to pathological processes (31). If soluble pro-
teins diffuse from cells and travel throughout
the body via the blood stream, then all of these
proteins in the blood should show a sequence
relationship to the cDNAs that are known to
be expressed in cells and tissues.
Mapping Exact MS/MS Peptide
Sequences to RefSeq
Most groups that provided peptide
sequence information showed a majority of
peptides in known human proteins in the
RefSeq NP. The number of sequences reported
by most groups was similar to the number of
amino acid sequences found in the set of
expressed human proteins. The presence of a
minority of hypothetical sequences and
sequences from other species that do not
match human sequences confirms that the
data were searched against broad genetic
databases containing many nonhuman
sequences as well as predicted gene products.
Nevertheless, the MS/MS spectra correlated
best to sequences found in the set of known
human proteins. We conclude that the majority
of groups seemed to show a strong bias
toward peptides that exist in the set of pro-
teins that are known to be expressed in
humans. For example, the data from ref. 9
originated from a search against a library that
contained mostly sequences that do not show
much homology to the known proteins in
Table 7
A Nonredundant Database of Human Serum 
and Plasma Proteins Assembled 
by BLASTp Matching at the 75% FL
and 20 Contiguous AA Levela











aThe total and cumulative proteins in agreement
between all the experiments summarized to date are
calculated alongside the number of groups reporting
that type of protein sequence.
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RefSeq (Table 2) and yet the spectra from that
study were still largely correlated to peptides
found in known human expression products.
Thus the MS/MS correlation algorithms
showed a strong bias against matching frag-
mentation spectra to physiologically irrelevant
XP sequences or sequences not found in human
beings. The data from ref. 9 in particular seem
to provide strong evidence that LC-MS/MS can
identify authentic human proteins even when
searched against a large and diverse database
of sequences that largely show low homology
to expressed human proteins.
Agreement Between BLAST and Exact
Peptide Sequence Methods
The set of NR proteins obtained by string
searches for the peptide sequences was com-
pared to BLAST analysis of the full-length
proteins. The absolute number of sequences
mapped to RefSeq was much larger using the
peptide method because the same peptides
sequences may be found in several proteins.
The peptide sequences from MS/MS correlation
were retained in the NR set of proteins obtained
from BLASTp in all cases. The two methods
produced similar trends and related sequences
but the BLAST method collapsed into smaller
number of NR proteins. Both methods are rea-
sonable approaches to mapping existing pro-
teomic data to a nonredundant subset of a
reference database for comparison. There are
experimental data from more groups available
in FASTA format and the BLASTp algorithm is
an open-source mainstay of bio-informatic
research and thus may be simpler method of
comparing data sets for many laboratories.
BLAST Mapping FASTA Files 
to a Common Set of RefSeq Entries
We observed that the serum proteome
expression lists contained relatively few
unknown RefSeq XP automated gene predic-
tions as compared to known NP entries. The
ratio of XPs to NPs may indicate that many
predicted XP proteins are not in fact expressed
and therefore are not detected by the LC-
MS/MS system. The data referenced (2,3,5,8,
9,11,31) may be interpreted to support the
capacity of correlation analysis of LC-MS/MS
spectra to identify the expressed proteins of 
an organism but to avoid implicating the
hypothetical proteins that are not actually
expressed. A preponderance of known pro-
teins was observed disproportionate to their
representation in the databases at the time
many of these studies were conducted. The
bias toward protein sequences that are known
to be expressed in humans instead of hypo-
thetical proteins is consistent with the pro-
posed cut-off scores for search algorithms to
accurately identify peptides from complex
mixtures most of the time (1,14,20). The abso-
lute discrepancy between the two related sets
of NR proteins defined by BLASTp matching
compared to exact peptide searches empha-
sizes the failure of MS/MS search algorithms
to discriminate between similar types of pro-
teins where limited sequence coverage is
available (5).
Agreement Between Groups
We observed that all groups showed some
agreement but that different groups observed
different subsets of RefSeq. To date there is
little replicate data available comparing the
effects of sample preparation methods with
the list of proteins obtained but, in general,
more proteins are observed with replication of
the same samples. The simplest explanation of
reduced agreement of low abundance proteins
might be that each group used different
sample preparation techniques, different search
engines, and different databases and thus
obtained a different subset of the proteome.
Additionally, most groups have not exhaus-
tively replicated the entire experiment and so
there may be some discrepancy from sampling
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error. The effect of sample preparation was
perhaps best exemplified by the difference
between ultra HPLC without sample prepara-
tion (9) that did not share about 30% of
sequences with the same experiment per-
formed after prefractionation (12).
Category Distributions
The BLAST algorithm produced smaller
NR data sets. Full FASTA data were available
for all groups. BLAST analysis of the pro-
teins was used to compare all the groups.
From the framework set out by ref. 2 the set
of high abundance proteins should be biased
toward secreted extracellular proteins and
the low abundance proteins should be
enhanced in soluble cytoplasmic proteins but
diminished in insoluble proteins from mem-
branes. Together, the increased diffusion of
soluble proteins and decreased representa-
tion of insoluble proteins should result in a
nonrandom distribution of serum proteins
that should show a significant bias away
from a random sampling of the RefSeq
database. All groups showed a significant
enhancement of extracellular and matrix pro-
teins that represent the high abundance
secreted proteins and many groups showed
higher frequencies of cytosolic or cytoskele-
tal proteins. However, most groups showed
a strong bias against mitocondrial proteins,
ribosomal proteins, membrane proteins, and
insoluble proteins. In this sense, the experi-
mental data are in agreement with the con-
cept that serum is comprised of two
populations of soluble proteins, one super
abundant (secreted proteins) and one low
abundant, that have diffused from their cells
or organs (2). However, although many pro-
teins have been identified, there is a need 
for a more resolved and highly reproduced
sampling of serum proteins to describe the
composition and structure of serum proteins
in detail.
Combined Plasma and Serum Protein
Database
Many of the MS/MS identifications reported
to date involve proteins where the sequence
coverage of MS/MS peptides is too small to
determine unequivocally which protein the
sequence is derived from and therefore can
only be used to report types of proteins (5).
Listing all of the many proteins that may con-
tain the exact MS/MS peptide sequence is not
the simplest way to present the data and
would imply that more proteins have been
identified than the evidence can support.
Exact peptide matching also leads to higher
calculated overlap values. Thus, there may
also be merit in the use of BLAST matching to
simplify and compare data sets if precautions
are taken to ensure that the resulting set of
representative protein sequences still contain
the original MS/MS peptides. Several meth-
ods have been used to unify the available
serum and plasma data with results ranging
from as few as 50 to as many as some 3000
proteins in agreement (20,31). The BLAST and
exact peptide sequence methods exhibited the
capacity to determine agreement between pro-
tein lists and showed that some 1671 types of
proteins are shared by at least three groups. So
far 3151 proteins have been implicated with
three peptides, i.e., about one-tenth of the
RefSeq database. We conclude that it will be
possible to develop openly available and stan-
dardized methods to compare between differ-
ent populations of results using BLAST
matching or exact peptide search strings.
Size Distribution of the Database
Blood is known to contain many very large
proteins such as apolipoproteins, comple-
ments, and glycoproteins that are known to be
processed in the blood. RefSeq NP contains
many precursor proteins and other full length
protein entries including some proteins that
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may contain many thousands of amino acids.
Some of these very long proteins may not exist
physiologically. Because about 90% of the pro-
teins in RefSeq are less than 1000 amino acids
long similar in proportion to the mass spec-
trometry data, it appears that the data base is
not skewed toward longer sequences from
random matches (32). The proteins with at
least two or three peptides remain well below
the size distribution curve of RefSeq, whereas
proteins with only one peptides exceeded the
size distribution of the RefSeq data base after
about 800 amino acids in length. Thus, the
proteins identified with two or three peptides
may be mostly reliable (33). However, for pro-
teins identified by only one peptides that are
greater than 800 amino acids in length it
appears that more false data is being collected
than the real data obtained. In summary, it
would seem that there are reliable peptide
ions known from about 3000 proteins that
might be detected from and quantified by LC-
MS with multiple ion monitoring on a triple
stage quadrupole mass spectrometer.
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